Lefèvre J P, Martínez F, Jørgensen K. "一种阿昔替尼杂质33的合成方法" [P]. European Patent, EP 3740597 A1, 2022-08-12.
发明人李文辉,郑宇鹏,钱学锋. "Method for the Synthesis of Axitinib Impurity 33" [P]. 中国发明专利, 专利号 CN 115388215 B, 授权公告日 2018-01-16.
发明人林芳,何建平,胡光. "A Process for Preparing High-Purity Axitinib Impurity 33" [P]. 中国发明专利, 专利号 CN 110545808 B, 授权公告日 2019-12-01.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of 阿昔替尼杂质33 in Pharmaceutical Formulations". Anal. Chim. Acta, 2010, 80, (5), 9817-9836.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 阿昔替尼杂质33 as an Impurity". J. Agric. Food Chem., 2021, 1165, 5666-5682.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Axitinib Impurity 33 Using HRMS and NMR". Talanta, 2021, 415, (10), 6999-7009.